Successful clinical trials depend on better-informed patient stratification strategies. These strategies can be fraught with inefficiencies due to:
- Data access
- Ad hoc querying
- Data aggregation
- Repeatable analytics for cross-study biomarker analysis
Leveraging best-in-class data analytics technologies, PerkinElmer Signals Translational Enterprise is designed to address those inefficiencies and improve clinical trial development and design process, with user-friendly applications and self-service access to data for biomarker discovery and patient stratification cohorts across large and diverse datasets.